Literature DB >> 10234841

Molecular determinants of the pathogenesis of disease due to non-typable Haemophilus influenzae.

V K Rao1, G P Krasan, D R Hendrixson, S Dawid, J W St Geme.   

Abstract

Non-typable Haemophilus influenzae is a common commensal organism in the human upper respiratory tract and an important cause of localized respiratory tract disease. The pathogenesis of disease begins with bacterial colonization of the nasopharynx, a process that involves establishment on the mucosal surface and evasion of local immune mechanisms. Under the proper circumstances, the organism spreads contiguously to the middle ear, the sinuses, or the lungs, and then stimulates a brisk inflammatory response, producing symptomatic infection. In this review, we summarize our present understanding of the molecular determinants of this sequence of events. Continued investigation of the molecular mechanism of non-typable H. influenzae pathogenicity should facilitate development of novel approaches to the treatment and prevention of H. influenzae disease.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10234841     DOI: 10.1111/j.1574-6976.1999.tb00393.x

Source DB:  PubMed          Journal:  FEMS Microbiol Rev        ISSN: 0168-6445            Impact factor:   16.408


  41 in total

Review 1.  Virulence functions of autotransporter proteins.

Authors:  I R Henderson; J P Nataro
Journal:  Infect Immun       Date:  2001-03       Impact factor: 3.441

2.  Characterization of non-type B Haemophilus influenzae strains isolated from patients with invasive disease. The HI Study Group.

Authors:  M Cerquetti; M L Ciofi degli Atti; G Renna; A E Tozzi; M L Garlaschi; P Mastrantonio
Journal:  J Clin Microbiol       Date:  2000-12       Impact factor: 5.948

3.  Evolutionary and functional relationships among the nontypeable Haemophilus influenzae HMW family of adhesins.

Authors:  Amy Z Buscher; Katie Burmeister; Stephen J Barenkamp; Joseph W St Geme
Journal:  J Bacteriol       Date:  2004-07       Impact factor: 3.490

Review 4.  Haemophilus influenzae: genetic variability and natural selection to identify virulence factors.

Authors:  Janet R Gilsdorf; Carl F Marrs; Betsy Foxman
Journal:  Infect Immun       Date:  2004-05       Impact factor: 3.441

5.  Novel sialic acid transporter of Haemophilus influenzae.

Authors:  Simon Allen; Anthony Zaleski; Jason W Johnston; Bradford W Gibson; Michael A Apicella
Journal:  Infect Immun       Date:  2005-09       Impact factor: 3.441

6.  Conservation and diversity of HMW1 and HMW2 adhesin binding domains among invasive nontypeable Haemophilus influenzae isolates.

Authors:  Maria Giufrè; Michele Muscillo; Patrizia Spigaglia; Rita Cardines; Paola Mastrantonio; Marina Cerquetti
Journal:  Infect Immun       Date:  2006-02       Impact factor: 3.441

7.  Complete genome sequence of Haemophilus somnus (Histophilus somni) strain 129Pt and comparison to Haemophilus ducreyi 35000HP and Haemophilus influenzae Rd.

Authors:  Jean F Challacombe; A J Duncan; Thomas S Brettin; David Bruce; Olga Chertkov; J Chris Detter; Cliff S Han; Monica Misra; Paul Richardson; Roxanne Tapia; Nina Thayer; Gary Xie; Thomas J Inzana
Journal:  J Bacteriol       Date:  2006-12-15       Impact factor: 3.490

8.  Crystal structure of the Haemophilus influenzae Hap adhesin reveals an intercellular oligomerization mechanism for bacterial aggregation.

Authors:  Guoyu Meng; Nicole Spahich; Roma Kenjale; Gabriel Waksman; Joseph W St Geme
Journal:  EMBO J       Date:  2011-08-12       Impact factor: 11.598

9.  Nontypeable Haemophilus influenzae clearance by alveolar macrophages is impaired by exposure to cigarette smoke.

Authors:  Pau Martí-Lliteras; Verónica Regueiro; Pau Morey; Derek W Hood; Carles Saus; Jaume Sauleda; Alvar G N Agustí; José Antonio Bengoechea; Junkal Garmendia
Journal:  Infect Immun       Date:  2009-07-20       Impact factor: 3.441

10.  Mucosal lipocalin 2 has pro-inflammatory and iron-sequestering effects in response to bacterial enterobactin.

Authors:  Michael A Bachman; Virginia L Miller; Jeffrey N Weiser
Journal:  PLoS Pathog       Date:  2009-10-16       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.